Epidemiologic studies from numerous disparate populations reveal that indiv
iduals with the habit of daily moderate wine consumption enjoy significant
reductions in all-cause and particularly cardiovascular mortality when comp
ared with individuals who abstain or who drink alcohol to excess. Researche
rs are working to explain this observation in molecular and nutritional ter
ms. Moderate ethanol intake from any type of beverage improves lipoprotein
metabolism and lowers cardiovascular mortality risk. The question now is wh
ether wine, particularly red wine with its abundant content of phenolic aci
ds and polyphenols, confers additional health benefits. Discovering the nut
ritional properties of wine is a challenging task, which requires that the
biological actions and bioavailability of the >200 individual phenolic comp
ounds be documented and interpreted within the societal factors that strati
fy wine consumption and the myriad effects of alcohol alone. Further challe
nge arises because the health benefits of wine address the prevention of sl
owly developing diseases for which validated biomarkers are rare. Thus, alt
hough the benefits of the polyphenols from fruits and vegetables are increa
singly accepted, consensus on wine is developing more slowly. Scientific re
search has demonstrated that the molecules present in grapes and in wine al
ter cellular metabolism and signaling, which is consistent mechanistically
with reducing arterial disease. Future research must address specific mecha
nisms both of alcohol and of polyphenolic action and develop biomarkers of
their role in disease prevention in individuals.